We want you to take advantage of everything Cancer Therapy Advisor has to offer. To view unlimited cont ...

In a survey last year by the American Medical Association, 93% of doctors said that insurers’ prior authorization practices ...

The FDA has approved Imfinzi (durvalumab) as neoadjuvant and adjuvant treatment in patients with muscle-invasive bladder cancer.

High-dose chemotherapy and HSCT can provide long-term benefits in patients with MCL, a retrospective study suggests.

Patients with metastatic NSCLC may benefit from continuing on pembrolizumab-based treatment after progressing on that ...

A top official at the FDA is stepping down, warning that the HHS secretary aims to spread misinformation and lies.

Pembrolizumab and concurrent CRT, followed by pembrolizumab consolidation, provided long-term tumor control in previously untreated, unresectable, stage III NSCLC.

The FDA has expanded the approval for Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to include patients with PSMA-positive mCRPC who have been treated with ARPI therapy and can delay chemotherapy.

Some patients with locally advanced esophageal cancer may be able to safely forgo esophagectomy after CRT, data suggest.

(HealthDay News) — Five leaders at the US Centers for Disease Control and Prevention (CDC) stepped down last week, according to The Associated Press, which confirmed the departures through 2 anonymous ...

(HealthDay News) — Grants from the National Institutes of Health (NIH) that were funding research on LGBTQ+ health have been canceled by the US government, alarming scientists who say the move will ...

Americans living in rural communities could see their access to health care diminish if Congress changes eligibility for Medicaid or significantly reduces funding.